Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,826 | 343 | 99.4% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $29.46 | 1 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $759.57 | 54 | $0 (2024) |
| Allergan Inc. | $713.98 | 50 | $0 (2018) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $614.61 | 42 | $0 (2024) |
| ABBVIE INC. | $501.42 | 33 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $270.29 | 23 | $0 (2024) |
| Gilead Sciences, Inc. | $245.04 | 27 | $0 (2018) |
| PFIZER INC. | $191.60 | 12 | $0 (2024) |
| UCB, Inc. | $155.06 | 11 | $0 (2018) |
| Intercept Pharmaceuticals, Inc. | $138.67 | 8 | $0 (2024) |
| Lilly USA, LLC | $111.60 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,311 | 64 | Janssen Biotech, Inc. ($268.78) |
| 2023 | $597.44 | 35 | Janssen Biotech, Inc. ($135.36) |
| 2022 | $104.36 | 3 | Boston Scientific Corporation ($98.48) |
| 2021 | $3.05 | 1 | PFIZER INC. ($3.05) |
| 2019 | $29.66 | 2 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($15.72) |
| 2018 | $1,801 | 147 | Allergan Inc. ($426.99) |
| 2017 | $1,008 | 92 | Allergan Inc. ($286.99) |
All Payment Transactions
344 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $19.39 | General |
| Category: Immunology | ||||||
| 12/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $24.40 | General |
| Category: Gastroenterology | ||||||
| 12/09/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $26.06 | General |
| Category: Immunology | ||||||
| 11/25/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/19/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.49 | General |
| Category: Immunology | ||||||
| 11/12/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $22.30 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/11/2024 | Enterra Medical, Inc. | — | Food and Beverage | In-kind items and services | $29.53 | General |
| 11/07/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $24.41 | General |
| Category: IMMUNOLOGY | ||||||
| 10/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $24.88 | General |
| Category: Gastroenterology | ||||||
| 10/30/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA | Food and Beverage | In-kind items and services | $124.74 | General |
| Category: Immunology | ||||||
| 10/25/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $25.37 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/25/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: Gastroenterology | ||||||
| 10/21/2024 | AIMMUNE THERAPEUTICS, INC. | VOWST (Biological) | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: GI | ||||||
| 10/16/2024 | Sandoz Inc. | — | Food and Beverage | In-kind items and services | $19.28 | General |
| 10/14/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $12.78 | General |
| Category: Gastroenterology | ||||||
| 10/03/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/02/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $12.18 | General |
| Category: Immunology | ||||||
| 09/26/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: Gastroenterology | ||||||
| 09/25/2024 | Mauna Kea Technologies, Inc. | — | Food and Beverage | Cash or cash equivalent | $17.31 | General |
| 09/23/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $10.68 | General |
| Category: Immunology | ||||||
| 09/18/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $25.63 | General |
| Category: Immunology | ||||||
| 09/16/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $24.19 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 09/16/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: Gastroenterology | ||||||
| 09/12/2024 | Mauna Kea Technologies, Inc. | — | Food and Beverage | Cash or cash equivalent | $14.39 | General |
| 09/10/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $20.22 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,167 | 1,392 | $441,856 | $141,997 |
| 2022 | 18 | 1,135 | 1,309 | $404,173 | $133,525 |
| 2021 | 19 | 1,232 | 1,462 | $442,839 | $142,624 |
| 2020 | 17 | 998 | 1,156 | $348,428 | $115,953 |
All Medicare Procedures & Services
72 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 262 | 431 | $61,202 | $26,339 | 43.0% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 111 | 111 | $54,723 | $20,824 | 38.1% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 91 | 91 | $44,954 | $17,049 | 37.9% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 88 | 89 | $58,941 | $13,137 | 22.3% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 49 | 49 | $34,823 | $10,469 | 30.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 100 | 119 | $23,919 | $9,716 | 40.6% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 118 | 118 | $53,336 | $9,663 | 18.1% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 42 | 42 | $20,460 | $5,952 | 29.1% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2023 | 42 | 49 | $21,462 | $5,757 | 26.8% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 65 | 65 | $21,125 | $5,059 | 23.9% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 51 | 78 | $9,048 | $3,889 | 43.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 52 | 52 | $9,100 | $3,865 | 42.5% |
| 45384 | Removal of polyps or growths of large bowel using a flexible endoscope with electrical cautery | Facility | 2023 | 16 | 16 | $10,200 | $2,590 | 25.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 24 | 24 | $6,288 | $2,544 | 40.5% |
| 43237 | Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope through mouth | Facility | 2023 | 13 | 13 | $6,708 | $2,070 | 30.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 12 | 13 | $2,743 | $1,348 | 49.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 17 | 18 | $1,998 | $1,155 | 57.8% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 14 | 14 | $826.00 | $570.50 | 69.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 222 | 313 | $44,446 | $18,821 | 42.3% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 91 | 91 | $44,900 | $17,852 | 39.8% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 91 | 91 | $58,149 | $13,773 | 23.7% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 55 | 55 | $27,170 | $10,848 | 39.9% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 101 | 107 | $48,364 | $9,670 | 20.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 83 | 100 | $20,100 | $8,916 | 44.4% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 59 | 59 | $26,845 | $8,700 | 32.4% |
About Dr. Richard Wille, MD
Dr. Richard Wille, MD is a Gastroenterology healthcare provider based in Troy, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/16/2005. The National Provider Identifier (NPI) number assigned to this provider is 1689656662.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Richard Wille, MD has received a total of $4,855 in payments from pharmaceutical and medical device companies, with $1,311 received in 2024. These payments were reported across 344 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($4,826).
As a Medicare-enrolled provider, Wille has provided services to 4,532 Medicare beneficiaries, totaling 5,319 services with total Medicare billing of $534,099. Data is available for 4 years (2020–2023), covering 72 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location Troy, MI
- Active Since 11/16/2005
- Last Updated 09/17/2013
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1689656662
Products in Payments
- LINZESS (Drug) $628.02
- STELARA (Biological) $585.91
- XIFAXAN (Drug) $339.69
- VIBERZI (Drug) $209.87
- RINVOQ (Biological) $192.71
- TREMFYA (Drug) $173.66
- DUPIXENT (Biological) $158.50
- Cimzia (Drug) $155.06
- ZENPEP (Drug) $128.42
- Amitiza (Drug) $119.74
- Entyvio (Biological) $115.92
- OMVOH (Drug) $111.60
- OCALIVA (Drug) $106.52
- RELISTOR (Drug) $103.92
- SpyGlass (Device) $98.48
- ENTYVIO (Biological) $96.89
- EUCRISA (Drug) $95.41
- Humira (Biological) $88.28
- APRISO (Drug) $88.13
- XELJANZ (Drug) $74.07
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Troy
Dr. Partha Nandi, Md, MD
Gastroenterology — Payments: $242,021
Dr. Barry Pronold, M.d, M.D
Gastroenterology — Payments: $17,199
Dr. John Weber, Md, MD
Gastroenterology — Payments: $14,828
Dr. Mehmet Donat, Md, MD
Gastroenterology — Payments: $8,874
Dr. Robert Lamport, Md, MD
Gastroenterology — Payments: $7,628
Dr. Sante Bologna, Md, MD
Gastroenterology — Payments: $3,761